Engineering An Improved Cell Cycle-Regulatable Herpes Simplex Virus Type 1 Amplicon Vector with Enhanced Transgene Expression in Proliferating Cells yet Attenuated Activities in Resting Cells-Reference-Cited by-同舟云学术

Engineering An Improved Cell Cycle-Regulatable Herpes Simplex Virus Type 1 Amplicon Vector with Enhanced Transgene Expression in Proliferating Cells yet Attenuated Activities in Resting Cells

Published:2007-03 Issue:3 Volume:18 Page:222-231
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Wang Grace Y.¹,Ho Ivy A.W.¹,Sia Kian C.¹,Miao L.¹,Hui Kam M.¹,Lam Paula Y.P.¹

Affiliation:

1. Gene Vector Laboratory, Division of Cellular and Molecular Research, National Cancer Centre Singapore, Singapore 169610.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2006.140

Reference21 articles.

1. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

2. Structure and cell cycle-regulated transcription of the human cyclin A gene.

3. Glioma-Specific and Cell Cycle-Regulated Herpes Simplex Virus Type 1 Amplicon Viral Vector

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential application of a transcriptionally regulated oncolytic herpes simplex virus for human cancer therapy;British Journal of Cancer;2013-11-05

2. Preclinical Evaluation of Transcriptional Targeting Strategy for Human Hepatocellular Carcinoma in an Orthotopic Xenograft Mouse Model;Molecular Cancer Therapeutics;2013-05-29

3. FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors;Molecular Cancer;2010-10-13

4. Human hepatocellular carcinoma: Expression profiles-based molecular interpretations and clinical applications;Cancer Letters;2009-12

5. Imaging and therapy of experimental schwannomas using HSV amplicon vector-encoding apoptotic protein under Schwann cell promoter;Cancer Gene Therapy;2009-10-16